Phase I-II Study of Advanced Head and Neck Squamous Cell Carcinoma Patients Treated With Recombinant Human Interferon Gamma
- 1 November 1990
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Otolaryngology–Head & Neck Surgery
- Vol. 116 (11), 1271-1277
- https://doi.org/10.1001/archotol.1990.01870110043004
Abstract
Research from JAMA Otolaryngology–Head & Neck Surgery — Phase I-II Study of Advanced Head and Neck Squamous Cell Carcinoma Patients Treated With Recombinant Human Interferon GammaThis publication has 12 references indexed in Scilit:
- Low-Dose Interferon Alfa-2b in the Treatment of Hairy Cell LeukemiaJNCI Journal of the National Cancer Institute, 1989
- Lysis of Squamous Cell Carcinoma Via Antibody-Dependent Cellular CytotoxicityJAMA Otolaryngology–Head & Neck Surgery, 1989
- INDUCTION OF HLA-DR ANTIGEN ON HUMAN SQUAMOUS CARCINOMA BY RECOMBINANT INTERFERON GAMMAThe Laryngoscope, 1988
- Interferon Gamma Induced Oncolysis: An Effect on Head and Neck Squamous Carcinoma CulturesJAMA Otolaryngology–Head & Neck Surgery, 1988
- Adhesion of T lymphoblasts to epidermal keratinocytes is regulated by interferon gamma and is mediated by intercellular adhesion molecule 1 (ICAM-1).The Journal of Experimental Medicine, 1988
- Phase I study of multiple dose intramuscularly administered recombinant gamma interferon.Journal of Clinical Oncology, 1986
- PHASE-I TRIAL OF RECOMBINANT INTERFERON GAMMA BY 1-HOUR IV INFUSION1986
- Phase I trial of recombinant interferon gamma in cancer patients.Journal of Clinical Oncology, 1986
- Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma.The Journal of Experimental Medicine, 1984
- IMMUNOHISTOCHEMICAL ANALYSIS OF MALIGNANT MELANOMAS AND NEVOCELLULAR NEVI WITH MONOCLONAL-ANTIBODIES TO DISTINCT MONOMORPHIC DETERMINANTS OF HLA ANTIGENS1984